Marshall Wace LLP Sells 275,591 Shares of Colgate-Palmolive (NYSE:CL)

Marshall Wace LLP trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 85.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 47,443 shares of the company’s stock after selling 275,591 shares during the quarter. Marshall Wace LLP’s holdings in Colgate-Palmolive were worth $4,604,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Dorsey & Whitney Trust CO LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $218,000. Jones Financial Companies Lllp lifted its position in Colgate-Palmolive by 4.8% in the fourth quarter. Jones Financial Companies Lllp now owns 4,873 shares of the company’s stock valued at $388,000 after purchasing an additional 222 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Colgate-Palmolive by 6.3% in the fourth quarter. The Manufacturers Life Insurance Company now owns 694,659 shares of the company’s stock worth $55,371,000 after purchasing an additional 40,966 shares during the last quarter. CWA Asset Management Group LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $585,000. Finally, NEOS Investment Management LLC raised its holdings in Colgate-Palmolive by 42.1% during the 4th quarter. NEOS Investment Management LLC now owns 11,669 shares of the company’s stock valued at $930,000 after buying an additional 3,457 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. BNP Paribas began coverage on shares of Colgate-Palmolive in a research note on Monday, June 24th. They issued an “outperform” rating and a $109.00 price target for the company. Wells Fargo & Company downgraded Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 target price on the stock. in a report on Monday, September 16th. Citigroup raised their target price on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Finally, UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $104.74.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last ninety days. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 1.4 %

CL stock opened at $102.31 on Wednesday. The stock has a market capitalization of $83.94 billion, a P/E ratio of 32.38, a P/E/G ratio of 3.62 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $109.30. The business has a fifty day moving average price of $103.48 and a 200-day moving average price of $96.62.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the firm posted $0.77 EPS. The business’s quarterly revenue was up 4.9% compared to the same quarter last year. Equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 1.95%. Colgate-Palmolive’s payout ratio is 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.